Table 3.
Summary of liver toxicity of triclosan.
Models | Hepatotoxic effects | References |
---|---|---|
C57BL/6 mice | TCS-exposed mice showed hepatic hypertrophy, increase in liver lipid levels, and upregulation of fatty acid oxidation and inflammation-related genes. | Huang et al., 2020 |
C57BL/6 mice | TCS aggravated high-fat diet-induced metabolic disorders by disrupting the regulation of FGF21 expression. | Yueh et al., 2020 |
Sprague Dawley (SD) rats | More upregulated genes in carbohydrate and lipid metabolic pathways were observed in aged rats as TCS exposure contributed to metabolic disturbance and these effects would accumulate over time. | Ma et al., 2020 |
C57/B6 mice | TCS transmission through lactation resulted in adipogenesis, ER stress, PPARα activation, immune inflammation in the neonatal liver, and nonalcoholic fatty liver disease in neonatal C57/B6 mice. | Weber et al., 2022 |
Zebrafish | TCS regulated fto-mediated m6 methylation by inhibiting miR-30b expression, which led to the disturbance of lipid metabolism and elevation of TG and TC levels in zebrafish. | Sun et al., 2021a |
Zebrafish | Severe hepatocyte atrophy and necrosis in the liver tissue of zebrafish larvae after TCS exposure, with a marked increase in the gap between the liver plates. | Liu et al., 2019 |
Mosquito fish | TCS exposure perturbed the antioxidant system in mosquito fish liver tissues, and a number of oxidative stress-related biomarkers were displayed in a concentration-dependent (e.g. NQO1 mRNA, CAT mRNA) and/or time-dependent (e.g. GSH content) manner. | Bao et al., 2021 |
HepG2 cells | TCS treatment significantly restrained DNA methylation levels and suppressed DNA methyltransferase 1 activity in HepG2 cells. | Ma et al., 2013 |